Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
NCT ID: NCT05694273
Last Updated: 2024-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
2000 participants
OBSERVATIONAL
2025-01-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Complex Arrhythmia Registry
NCT07024927
Effect of Blood Pressure on Cardiovascular Outcomes and Recurrence After Catheter Ablation in Patients With Atrial Fibrillation
NCT06433336
Application Value of Whole-procedure Optimization for Catheter Ablation of Atrial Fibrillation
NCT06145906
A New Approach for Catheter Ablation of Atrial Fibrillation
NCT05989321
The Influence of Catheter Ablation for Atrial Fibrillation on Atrial Electrical
NCT03322085
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ischemic stroke group
1. Ischemic stroke secondary to patients receiving catheter ablation.
2. Ischemic stroke met the diagnostic criteria of the 2018 edition of the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke, and was confirmed by cranial CT/MRI scan.
No interventions assigned to this group
Transient ischemic attack group
1. Transient ischemic attack secondary to patients receiving catheter ablation.
2. Ischemic stroke met the diagnostic criteria of the 2018 edition of the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke, and was confirmed negative of new onset of infarction by cranial CT/MRI scan.
No interventions assigned to this group
Cerebral hemorrhage group
1. Cerebral hemorrhage secondary to patients receiving catheter ablation.
2. Cerebral hemorrhage met the diagnostic criteria of the 2021 Chinese Guidelines for the Diagnosis and Treatment of cerebral hemorrhage and was confirmed by head CT/MRI.
No interventions assigned to this group
Contral group
Patients who did not experience acute cerebrovascular events in the hospital.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* 2\. Patients \< 18 years or \> 80 years;
* 3\. Patients with uncomplete clinical data.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaanxi Provincial People's Hospital
OTHER
521 Hospital of NORINCO Group
OTHER
Xiangyang Central Hospital
OTHER
Ankang Central Hospital
OTHER
Baoji Central Hospital
OTHER
Luoyang Central Hospital
OTHER
Tianjin Medical University Second Hospital
OTHER
Fu Wai Hospital, Beijing, China
OTHER
Fuwai Yunnan Cardiovascular Hospital
OTHER
Chinese Academy of Medical Sciences, Fuwai Hospital
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guoliang Li
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital Xi'an Jiaotong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of Xian Jiantong University
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XJTU1AF2023LSK-531
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.